Publication & Citation Trends
Publications
25 total
Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes
Cited by 1
Semantic Scholar
Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes
Cited by 3
Semantic Scholar
Immunogenicity and safety of beta variant COVID-19 vaccine AZD2816 and AZD1222 (ChAdOx1 nCoV-19) as primary-series vaccination for previously unvaccinated adults in Brazil, South Africa, Poland, and the UK: a randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study.
Cited by 3
Semantic Scholar
Immunogenicity and safety following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine with Matrix-MTM adjuvant (NVX-CoV2373) versus a primary series in people living with and without HIV-1 infection in South Africa: A randomized crossover phase 2a/2b trial OA
Cited by 3
Semantic Scholar
Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages OA
Cited by 33
Semantic Scholar
Longitudinal IgA and IgG Response, and ACE2 Binding Blockade, to Full-Length SARS-CoV-2 Spike Protein Variants in a Population of Black PLWH Vaccinated with ChAdOx1 nCoV-19 OA
Cited by 1
Semantic Scholar
Respiratory Syncytial Virus Prefusion F Protein Vaccine Is Efficacious in Older Adults With Underlying Medical Conditions OA
Cited by 45
Semantic Scholar
Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005) OA
Cited by 4
Semantic Scholar
Research Topics
SARS-CoV-2 and COVID-19 Research
(22)
COVID-19 Clinical Research Studies
(13)
Vaccine Coverage and Hesitancy
(11)
Diabetes Treatment and Management
(4)
Monoclonal and Polyclonal Antibodies Research
(3)
Affiliations
MACOM (United States)
University of the Witwatersrand
Anna Needs Neuroblastoma Answers
Soweto CTC
Centre for Advanced Study